Lift Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
17
Lift Therapeutics General Information
Description
Developer of a biotech platform designed for CAR neutrophil cell therapy that helps overcome the limitations of current therapies in solid tumors. The company's platform offers immunomodulatory alpha neutrophils (IMANs) that turn the tumor microenvironment and recruit the rest of the immune system to destroy the lasting immunity by using stem cells, which is a proprietary media and genetic engineering, enabling healthcare providers to use CAR-IMAN cells to give patients potentially the cancer-killing ability they naturally possess.
Contact Information
Website
www.lift-tx.comCorporate Office
- London BioScience Innovation Centre
- 2 Royal College Street
- London NW1 0NH
- England, United Kingdom
Corporate Office
- London BioScience Innovation Centre
- 2 Royal College Street
- London NW1 0NH
- England, United Kingdom
Lift Therapeutics Timeline
Lift Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Accelerator/Incubator | 19-Jan-2026 | Completed | Pre-Clinical Trials | |||
| 13. Grant | 29-Jul-2025 | Completed | Pre-Clinical Trials | |||
| 12. Later Stage VC (Series A) | 07-May-2024 | Completed | Pre-Clinical Trials | |||
| 11. Grant | 09-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 10. Accelerator/Incubator | 01-Sep-2023 | Completed | Pre-Clinical Trials | |||
| 9. Later Stage VC | 01-Mar-2023 | Completed | Pre-Clinical Trials | |||
| 8. Seed Round | 17-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC (Series A) | 01-Apr-2020 | Cancelled | Pre-Clinical Trials | |||
| 6. Seed Round | 15-Jan-2020 | $699K | $3.18M | Completed | Pre-Clinical Trials | |
| 5. Accelerator/Incubator | 12-Feb-2019 | $961K | $2.48M | Completed | Pre-Clinical Trials |
Lift Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Preferred Shares | ||||||||
| Series A Preferred Shares | ||||||||
| Seed-2 Preferred Shares | ||||||||
| Seed-2 Preferred Shares | ||||||||
| Seed-1 Preferred Shares | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,596 | $0.012495 | $639.74 | $639.74 | 1x | $639.74 | 4.4% | |
| Ordinary | 1,290 | $0.012495 | $624.75 | $624.75 | 1x | $624.75 | 3.56% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lift Therapeutics Patents
Lift Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202413837-D0 | Combinatorial treatment | Inactive | 19-Sep-2024 | ||
| WO-2026062398-A1 | Combinatorial treatment | Pending | 19-Sep-2024 | ||
| GB-202413845-D0 | Granulocytes and granulocyte precursors | Inactive | 19-Sep-2024 | ||
| WO-2026062399-A1 | Granulocytes and granulocyte precursors | Pending | 19-Sep-2024 | ||
| GB-202413835-D0 | Preparation of cells | Inactive | 19-Sep-2024 |
Lift Therapeutics Signals
Lift Therapeutics Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Japan External Trade Organization | Accelerator/Incubator | |||
| Department of Enterprise, Trade and Employment | Government | |||
| ScaleReady | Corporation | |||
| Sijbrandij Foundation | Corporation | Minority | ||
| Grow London | Accelerator/Incubator |
Lift Therapeutics FAQs
-
When was Lift Therapeutics founded?
Lift Therapeutics was founded in 2014.
-
Where is Lift Therapeutics headquartered?
Lift Therapeutics is headquartered in London, United Kingdom.
-
What is the size of Lift Therapeutics?
Lift Therapeutics has 22 total employees.
-
What industry is Lift Therapeutics in?
Lift Therapeutics’s primary industry is Biotechnology.
-
Is Lift Therapeutics a private or public company?
Lift Therapeutics is a Private company.
-
What is Lift Therapeutics’s current revenue?
The current revenue for Lift Therapeutics is .
-
How much funding has Lift Therapeutics raised over time?
Lift Therapeutics has raised $21.8M.
-
Who are Lift Therapeutics’s investors?
Japan External Trade Organization, Department of Enterprise, Trade and Employment, ScaleReady, Sijbrandij Foundation, and Grow London are 5 of 17 investors who have invested in Lift Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process